Home
>
National Drug Code (NDC)
>
FEIBA
FEIBA - 64193-225-02 - (Anti-Inhibitor Coagulant Complex)
Drug Information of FEIBA
| Product NDC: | 64193-225 |
| Proprietary Name: | FEIBA |
| Non Proprietary Name: | Anti-Inhibitor Coagulant Complex |
| Active Ingredient(s): | & nbsp; Anti-Inhibitor Coagulant Complex |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of FEIBA
| Product NDC: | 64193-225 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA101447 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19860131 |
Package Information of FEIBA
| Package NDC: | 64193-225-02 |
| Package Description: | 1 KIT in 1 CARTON (64193-225-02) * 50 mL in 1 BOTTLE (64193-325-01) * 50 mL in 1 VIAL, GLASS (0338-0001-65) |
NDC Information of FEIBA
| NDC Code | 64193-225-02 |
| Proprietary Name | FEIBA |
| Package Description | 1 KIT in 1 CARTON (64193-225-02) * 50 mL in 1 BOTTLE (64193-325-01) * 50 mL in 1 VIAL, GLASS (0338-0001-65) |
| Product NDC | 64193-225 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Anti-Inhibitor Coagulant Complex |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19860131 |
| Marketing Category Name | BLA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
